184 related articles for article (PubMed ID: 19414338)
21. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
[TBL] [Abstract][Full Text] [Related]
22. [Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcinoma].
Takemura M; Morimura K; Yoshida K; Fujiwara Y
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2143-6. PubMed ID: 21084814
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
Int J Cancer; 2006 Jun; 118(12):3084-8. PubMed ID: 16425285
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
Ishihama H; Chida M; Araki O; Karube Y; Seki N; Tamura M; Umezu H; Honma K; Masawa N; Miyoshi S
Jpn J Clin Oncol; 2009 Jan; 39(1):33-6. PubMed ID: 19015148
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between enzymatic activity and gene expression of orotate phosphoribosyl transferase (OPRT) in colorectal cancer].
Takumi O; Michiharu S; Kazuhiko N; Hajime N; Tsuyoshi O; Sumito S; Hirohiko K; Nagaoka I
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2515-9. PubMed ID: 12506474
[TBL] [Abstract][Full Text] [Related]
26. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil.
Yoshitomi I; Kawasaki G; Yanamoto S; Mizuno A
Oral Oncol; 2006 Oct; 42(9):880-7. PubMed ID: 16757204
[TBL] [Abstract][Full Text] [Related]
27. Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakanishi H; Miki T
J Urol; 2004 Feb; 171(2 Pt 1):605-10. PubMed ID: 14713770
[TBL] [Abstract][Full Text] [Related]
28. Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil.
Sakamoto E; Nagase H; Kobunai T; Oie S; Oka T; Fukushima M; Oka T
Biochem Biophys Res Commun; 2007 Nov; 363(1):216-22. PubMed ID: 17854773
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer.
Matsusaka S; Yamasaki H; Fukushima M; Wakabayashi I
Chemotherapy; 2007; 53(1):36-41. PubMed ID: 17192711
[TBL] [Abstract][Full Text] [Related]
31. Profiling of fluorouracil-related genes by microdissection technique in hepatocellular carcinoma.
Takahashi T; Yoshida H; Mamada Y; Taniai N; Mizuguchi Y; Shimizu T; Kakinuma D; Ishikawa Y; Akimaru K; Sugisaki Y; Tajiri T
Hepatogastroenterology; 2007 Sep; 54(78):1612-6. PubMed ID: 18019677
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
33. The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
Mizutani Y; Wada H; Fukushima M; Yoshida O; Ukimura O; Kawauchi A; Miki T
Eur J Cancer; 2001 Mar; 37(5):569-75. PubMed ID: 11290431
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].
Sakurai Y; Sakamoto K; Sugimoto Y; Yoshida I; Masui T; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Matsuura S; Tanaka H; Oka T; Fukushima M
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1017-22. PubMed ID: 16044965
[TBL] [Abstract][Full Text] [Related]
35. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
Hahnvajanawong C; Chaiyagool J; Seubwai W; Bhudhisawasdi V; Namwat N; Khuntikeo N; Sripa B; Pugkhem A; Tassaneeyakul W
World J Gastroenterol; 2012 Aug; 18(30):3955-61. PubMed ID: 22912546
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of orotate phosphoribosyltransferase in colorectal carcinoma and its correlations with toxicities of chemotherapy].
Dong Q; Huang S; Li Y; Liu J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1179-81. PubMed ID: 22931617
[TBL] [Abstract][Full Text] [Related]
37. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
Tateishi Y; Tatemoto Y; Ohno S; Morishita K; Ueta E; Yamamoto T
Cancer Lett; 2009 Feb; 274(2):187-93. PubMed ID: 18986760
[TBL] [Abstract][Full Text] [Related]
38. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
[TBL] [Abstract][Full Text] [Related]
39. Changes to the dihydropyrimidine dehydrogenase gene copy number influence the susceptibility of cancers to 5-FU-based drugs: Data mining of the NCI-DTP data sets and validation with human tumour xenografts.
Kobunai T; Ooyama A; Sasaki S; Wierzba K; Takechi T; Fukushima M; Watanabe T; Nagawa H
Eur J Cancer; 2007 Mar; 43(4):791-8. PubMed ID: 17254767
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumor effects of fleroxacin with 5-fluorouracil in vitro and in vivo for bladder cancer cell lines.
Nishikawa T; Kohjimoto Y; Nishihata M; Ebisuno S; Hara I
Urology; 2009 Dec; 74(6):1370-6. PubMed ID: 19428092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
